Keren Bahar Halpern
- Hepatology top 2%
- Immunology top 5%
- IL-33, ST2, and ILC Pathways 3
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
- Molecular Biology top 5%
- Single-cell and spatial transcriptomics 11
- Gut microbiota and health 4
- Gene Regulatory Network Analysis 3
- Biophysics top 2%
-
- Pancreatic function and diabetes 6
-
- Cancer Cells and Metastasis 5
-
- Diabetes and associated disorders 3
- Co-authors
- Shalev ItzkovitzAndreas E. MoorIdo AmitEfi E. MassasaShanie LandenEyal DavidAmir GiladiShani Ben‐Moshe
- Cited by
- HepatologyImmunologyCancer Research
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Keren Bahar Halpern
27 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Hepatology 471
- Immunology 595
- Cancer Research 386
- Molecular Biology 1.8k
- Biophysics 133
Countries citing papers authored by Keren Bahar Halpern
This map shows the geographic impact of Keren Bahar Halpern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Bahar Halpern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Bahar Halpern more than expected).
Fields of papers citing papers by Keren Bahar Halpern
This network shows the impact of papers produced by Keren Bahar Halpern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Bahar Halpern. The network helps show where Keren Bahar Halpern may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keren Bahar Halpern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 31 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 43 | |
| 8 | 2021 | 86 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 100 | |
| 11 | 2020 | 30 | |
| 12 | 2018 | 244 | |
| 13 | 2018 | 56 | |
| 14 | 2018 | 281 | |
| 15 | Single-cell spatial reconstruction reveals global division of labour in the mammalian liverbreakdown → | 2017 | 685 |
| 16 | 2016 | 56 | |
| 17 | 2015 | 196 | |
| 18 | 2015 | 188 | |
| 19 | 2014 | 89 | |
| 20 | 2012 | 39 |
About Keren Bahar Halpern
Keren Bahar Halpern is a scholar working on Aging, Cancer Research and Immunology, having authored 28 papers that have together received 2.9k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (11 papers), Pancreatic function and diabetes (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (4 papers), Gut microbiota and health (4 papers), Gene Regulatory Network Analysis (3 papers), IL-33, ST2, and ILC Pathways (3 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Hepatology (471 citations), Immunology (595 citations) and Cancer Research (386 citations). Keren Bahar Halpern has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Shalev Itzkovitz, Andreas E. Moor, Ido Amit, Efi E. Massasa, Shanie Landen, Eyal David, Amir Giladi, Shani Ben‐Moshe, Beáta Tóth and Milena Rozenberg. Their work appears in journals such as Nature Metabolism, Nature Communications, Cell Reports, Nature and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.